Omega-3 Pharma Grade Benefits
Omega-3 APIs are approved for the treatment of hypertriglyceridemia, arteriosclerosis obliterans, and coronary heart disease in various geographies around the world. In addition, Omega-3s are being researched as pharmaceuticals in numerous other conditions, including KD’s own ALFA product for familial adenomatous polyposis (FAP).
To meet the exacting demands of the pharmaceutical industry, KD Pharma produces oil to its proprietary KD-Pür® standard. The purity of Omega-3 fish oil is not only measured in the concentration of the individual fatty acid, but in several categories that determine overall quality. The KD Pharma Group measures purity using a combination of the following parameters:
- Concentration of individual fatty acids, such as EPA, DHA, DPA
- Concentrations of minor fatty acids down to levels less than 0.1%
- Contaminate levels such as heavy metals, PCB's or pesticides
- Product oxidation
- Polymer content
In order for a KD Pharma oil to be considered KD-Pür® it needs to achieve a high level of standard in each parameter. Twenty -five years of experience in separation technology has provided KD Pharma with the knowledge necessary to ensure batch-to-batch consistency. The KD-Pür® standard is what has made KD Pharma the largest manufacturer of Omega-3 APIs in the world.